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Dear Editor,
We read Benus and colleagues’ arti-
cle entitled ‘Impact of digestive and
oropharyngeal decontamination on
the intestinal microbrota in ICU
patients’ [1]. Benus tested the
hypothesis that selective decontami-
nation of the digestive tract (SDD)
may achieve its claimed beneﬁts by
leaving the anaerobic intestinal mic-
robiota unaffected, which indicates a
misunderstanding of SDD [2]. SDD
was designed based on the observa-
tion that critical illness changes
ﬂora. Critical illness promotes a shift
from normal (S. pneumoniae in the
throat and E. coli in the gut) towards
abnormal carriage (aerobic Gram-
negative bacilli and methicillin-
resistant Staphylococcus aureus)
and overgrowth of both. Parenteral
cefotaxime controls overgrowth of
‘normal’ ﬂora, whereas abnormal
ﬂora is controlled by enteral poly-
myxin/tobramycin. There are 60
randomised controlled trials (RCT)
and 10 meta-analyses conﬁrming that
SDD reduces pneumonia (72%),
septicaemia (37%) and mortality
(29%) without resistance emerging.
Benus’s article focuses on ‘selec-
tivity’. Anaerobes rarely cause
infections; instead, the indigenous
anaerobic ﬂora contributes to physi-
ology and control of abnormal
carriage, i.e. it promotes colonisation
resistance (CR) [3]. Antimicrobials
suppressing anaerobes are ‘non-
selective’, those leaving them virtu-
ally intact are ‘selective’.
Using ﬂuorescent in situ hybrid-
ization, Benus demonstrates that SDD
impacts the indigenous ﬂora, partic-
ularly Faecalibacterium prausnitzii,
an anaerobic Gram-negative bacillus
signiﬁcantly reduced by high faecal
tobramycin levels. They hypothesize
that F. prausnitzii plays a role in
maintaining CR, therefore SDD can-
not be beneﬁcial by leaving colonic
microbiota unaffected. Interestingly,
the faecal samples studied by Benus
were collected from ICU patients
enrolled in a recent RCT showing
efﬁcacy and safety of SDD [1].
The only conclusion is that SDD is
effective and safe although not
selective, as described by Vollaard
et al. [3]. Donskey [4] wrote that SDD
has tremendous potential although it
is not truly selective.
Six healthy volunteers were chal-
lenged with cefotaxime-resistant
Enterobacter cloacae after intrave-
nous administration of cefotaxime
[3]. All became carriers, ﬁve experi-
enced overgrowth, and all cleared the
strain during pre-treatment without
cefotaxime. Parenteral cefotaxime
was chosen for SDD [2] as it has been
shown to control overgrowth of nor-
mal ﬂora through its high salivary
and biliary concentrations. These
levels are also bactericidal against
Clostridium species, Gram-positive
bacilli amongst the indigenous
anaerobes, and are thought to
contribute to CR [5].
Benus assessed the impact of
SDD on CR in 17 ICU patients and
reports a signiﬁcant reduction in
F. prausnitzii, which is hypothesized
to play a role in maintaining CR, in
contrast to Wensinck who showed
that CR is based on anaerobic Gram-
positive Clostridium species. Hence,
Benus concludes that SDD is not
selective.
Benus fails to acknowledge
Vollaard’s and Donskey’s work,
although both are relevant to the
assertion that SDD is a contradiction
in terms, i.e., effective decontamina-
tion or eradication of gut overgrowth
whilst maintaining complete selec-
tivity does not make sense. However,
the originators of SDD have always
been aware of this contradiction in
terms [2] preferring effectivity over
selectivity, if negative consequences
of non-selectivity are neutralised by
enteral antimicrobials (polymyxin/
tobramycin/amphotericin B).
In conclusion, SDD exerts beneﬁts
via antimicrobial concentrations
effective against overgrowth of nor-
mal and abnormal ﬂora rather than by
sparing the CR ﬂora. The clinical
impact of F. prausnitzii reduction in
the critically ill is unclear.
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